Medicine and Dentistry
Biological Marker
100%
Patient
99%
Assay
82%
Plasma
78%
Thrombin
70%
Activated Protein C Resistance
66%
Inpatient
52%
microRNA
51%
Donor
44%
Hemostat
41%
Contraceptive Agent
39%
Thrombosis
39%
Procoagulant
39%
Acute Leukemia
36%
Circulating microRNA
36%
Cells
36%
Malignant Neoplasm
35%
Therapeutic Procedure
32%
Disseminated Intravascular Coagulation
31%
Woman
31%
Oral Contraceptive
31%
Septic Shock
31%
Acute Myeloid Leukemia
31%
Leukemia Cell
31%
Nucleosome
31%
Observational Study
31%
COVID-19
31%
Vascular Endothelium
31%
Clinical Study
31%
Betrixaban
31%
Multidrug Resistance
31%
Blood Stasis
31%
Metabolism
31%
Postmenopause
31%
HL60
31%
Estetrol
31%
Bone Turnover
31%
Diffuse Large B-Cell Lymphoma
31%
Placebo
31%
Drug Resistance
26%
Spontaneous Remission
23%
Histone
23%
Antithrombotic
23%
Heparin
23%
Thromboplastin
22%
Lipid
18%
Activated Protein C
17%
Factor V Leiden
16%
APC
15%
Coagulation
15%
Pharmacology, Toxicology and Pharmaceutical Science
Activated Protein C Resistance
63%
Thrombin
45%
Acute Leukemia
42%
Clotting Time
37%
Multiple Drug Resistance
31%
Edoxaban
31%
Betrixaban
31%
Disseminated Intravascular Clotting
31%
Clinical Study
31%
Paroxysmal Nocturnal Hemoglobinuria
31%
Eculizumab
31%
microRNA
31%
Acute Myeloid Leukemia
31%
Multidrug Resistance Protein 1
31%
Procoagulant
31%
DNA Methyltransferase 3A
31%
Histone Methyltransferase
31%
Prothrombin
27%
Malignant Neoplasm
21%
Cytomegalovirus
21%
Venous Thromboembolism
15%
Heparin
15%
Blood Clotting Factor 10a Inhibitor
15%
Estrogen Receptor
15%
Thromboplastin
13%
Activated Protein C
12%
Blood Clotting Factor 5 Leiden
12%
Anticoagulant Agent
12%
Promyelocytic Leukemia
10%
Buffer
10%
Relapse
10%
Low Molecular Weight Heparin
10%
microRNA 20a
10%
Circulating microRNA
10%
Phospholipid
10%
Biological Marker
10%
Fondaparinux
10%
Nucleic Acid
10%
Luciferase
10%
Cell Death
10%
Lysine
10%
Histone H3
10%
Amine
10%
Quinazoline
10%
DNA Methyltransferase
10%
Lymphoma
10%
Methyltransferase
10%
DNA (Cytosine 5) Methyltransferase 1
10%
Fibrinolytic Agent
9%
Direct Oral Anticoagulant
9%
Nursing and Health Professions
Thrombin
63%
Standardization
39%
APC
31%
Edoxaban
31%
Sample
31%
Eculizumab
31%
Woman
31%
Placebo
31%
Bone Turnover
31%
Estetrol
31%
Paroxysmal Nocturnal Hemoglobinuria
31%
Pathophysiology
31%
Anticoagulant Agent
25%
Analyzer
23%
Lipid
18%
Parameters
16%
Patient
15%
Blood Clotting Time
13%
Carbohydrate
13%
Procoagulant
11%
Thrombocyte Free Plasma
11%
Reproducibility
9%
Fibrinolytic Agent
9%
Sex Hormone Binding Globulin
9%
Flow Cytometry
7%
Low Molecular Weight Heparin
7%
Laboratory
7%
Experiment
7%
Time
7%
Control
7%
Temperature
7%
Steroid
6%